Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Avance Clinical today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.
-
Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials
-
Certara celebrates its 200 published papers and 11 scientists on the Stanford/Elsevier top 2% cited researchers list in 2025.
-
Precede Biosciences Presents New Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in SCLC
-
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study using New Alternate Methodologies (NAM)-based...
-
MANCHESTER, United Kingdom and HYDERABAD, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced...
-
Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Microfluidics Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The global microfluidics market is poised...
-
Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Flow Cytometry Services Market Industry Trends and Global Forecasts to 2035: Distribution by Service, Type of Analysis based Flow Cytometric Services,...
-
ヴァルムエックス (VarmX)、日本の規制当局である医薬品医療機器総合機構 (PMDA) からリード資産VMX-C001に対する第I相試験免除を取得 日本の規制当局である医薬品医療機器総合機構 (PMDA)...
-
Drug developer VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001, enabling it to go straight to Phase 3 studies in Japan.